Silence Therapeutics (SLN) Current Leases (2019 - 2026)
Silence Therapeutics recorded quarterly Current Leases of $93000.0 in Q1 2026, up 4.49% quarter-over-quarter from $89000.0 in Q4 2025, and up 55.0% year-over-year from $60000.0 in Q1 2025.
Silence Therapeutics' Current Leases history runs 8 years deep, the most recent figure standing at $93000.0 for Q1 2026.
- In Q1 2026, Current Leases rose 55.0% year-over-year to $93000.0; the TTM figure through Mar 2026 stood at $93000.0 (up 55.0% YoY), while the FY2025 annual figure was $89000.0, down 23.93% from the prior year.
- Current Leases came in at $93000.0 for Q1 2026 at Silence Therapeutics, up from $89000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $523126.0 in Q4 2022 to a low of -$588095.6 in Q3 2022.
- A 5-year average of -$90187.4 and a median of -$150684.0 in 2024 frame the typical range for Current Leases.
- Across the five-year window, Current Leases surged 183.26% in 2022 and slumped 278.37% in 2023, its largest moves.
- Silence Therapeutics' Current Leases stood at $523126.0 in 2022, then tumbled by 142.47% to -$222166.2 in 2023, then soared by 152.66% to $117000.0 in 2024, then slipped by 23.93% to $89000.0 in 2025, then advanced by 4.49% to $93000.0 in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $93000.0, $89000.0, and $85000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 83,991.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 720.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 45.66 Mn |
| 10 | Silence Therapeutics | 924.61 Mn | 854.53 Mn | 411,000.00 | 93,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 93,000.00 |
| Dec 31, 2025 | 89,000.00 |
| Sep 30, 2025 | 85,000.00 |
| Mar 31, 2025 | 60,000.00 |
| Dec 31, 2024 | 117,000.00 |
| Sep 30, 2024 | -180,602.72 |
| Jun 30, 2024 | -232,248.62 |
| Mar 31, 2024 | -233,407.35 |
| Dec 31, 2023 | -222,166.19 |
| Sep 30, 2023 | -254,603.64 |
| Jun 30, 2023 | -247,769.90 |
| Mar 31, 2023 | -264,981.08 |
| Dec 31, 2022 | 523,126.03 |
| Sep 30, 2022 | -588,095.60 |
| Jun 30, 2022 | -65,484.34 |
| Mar 31, 2022 | -120,765.21 |
| Dec 31, 2021 | 184,677.45 |
| Sep 30, 2021 | -180,594.42 |
| Jun 30, 2021 | -250,193.36 |
| Dec 31, 2020 | 450,273.79 |
| Jun 30, 2020 | -18,625.43 |
| Dec 31, 2019 | 369,003.05 |